Interview with Ralf Jahns, MD of Research2Guidance & Susanne Gruber, Allis Health’s DTx channel Ambassador
At this year’s Frontiers Health, one of the most prominent global digital health innovation events, Allis.Health, a global digital health analyst platform, garnered attention with its panel discussion on “How to Successfully Manage a Digital Health Business: Monitoring, Organization, and Partnerships.” In an interview with Nicole Raleigh, Web Editor for Pharmaphorum, Ralf Jahns, MD of Research2Guidance (the company behind Allis.Health), and Susanne Gruber, Global Healthcare Advisor & Allis.Health’s DTx channel Ambassador, delved into the intricacies of the platform and what sets it apart in the market.
Highlights from the interview:
In the evolving landscape of digital health innovation, Allis Health is designed as a global digital health analyst platform, focusing on practical, data-driven market intelligence.
Drawing from extensive experience launching digital therapeutics globally, Susanne highlighted the challenge of navigating through the deluge of digital therapeutics news. As an ambassador, she plays a pivotal role in providing context and enhancing the value of news by connecting it to broader industry trends and company landscapes. Ambassadors contribute significantly to curating, interpreting, and contextualizing data, ensuring users receive insights that go beyond raw information.
Looking ahead, Ralf shared exciting plans for Allis.Health's growth. The platform is set to introduce new channels, including digital mental health, AI drug discovery, and digital supporter clinical trials. This expansion aims to cater to a broader spectrum of digital health enthusiasts, providing them with comprehensive market and competitor monitoring.
To learn more about Allis.Health we invite you to watch the interview with Ralf and Susanne. Enjoy!